Lacerda ALT

Department of Psychiatry and Medical Psychology, Universidade Federal de São Paulo, São Paulo, Brazil.

8 papers

ArticleKetamine

Subcutaneous Esketamine in Adolescents with Severe Depressive Episodes: A Five-Case Series.

Magalhães IPA, Lopes DN, Amato IA +6

Europe PMC2026
ArticleKetamine

Role of concomitant benzodiazepines, lithium, and lamotrigine in modulating the antidepressant effects of subcutaneous esketamine in patients with treatment-resistant depressive episodes: A retrospective naturalistic study.

Atidio JP, Delfino RS, Garios IS +8

Europe PMC2026
ArticleKetamine

Safety and efficacy with esketamine in treatment-resistant depression: long-term extension study.

Zaki N, Chen LN, Lane R +10

Europe PMC2025
ArticleKetamine

Arketamine: a scoping review of its use in humans.

Leal GC, Lima-Araújo I, Roiter DG +5

Europe PMC2025
ArticleKetamine

Ketamine for catatonia: A novel treatment for an old clinical challenge? A systematic review of the evidence.

Caliman-Fontes AT, Vieira F, Leal GC +7

Europe PMC2024
ArticleKetamine

Editorial: Perspectives on new fast-acting antidepressants.

Delfino RS, Singh B, Lacerda ALT

Europe PMC2024
ArticleKetamine

Does the intensity of dissociation predict antidepressant effects 24 hours after infusion of racemic ketamine or esketamine in treatment-resistant depression? A secondary analysis from a randomized controlled trial.

Echegaray MVF, Mello RP, Magnavita GM +16

Europe PMC2025
ArticleKetamine

Brain-derived neurotrophic factor serum levels following ketamine and esketamine intervention for treatment-resistant depression: secondary analysis from a randomized trial.

Caliman-Fontes AT, Leal GC, Correia-Melo FS +17

Europe PMC2023